Immune profiling identifies CD161+CD127+CD8+ T cells as a predictive biomarker for Anti-PD-L1 therapy response in the SCLC-I subtype

Abstract Background Advances in molecular subtype classification have improved the understanding of extensive-stage small cell lung cancer (ES-SCLC). However, immune landscape differences across ES-SCLC subtypes remain poorly defined. This study aimed to characterize ES-SCLC immune profiles and expl...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jingjing Qu, Wenjia Sun, Yuekang Li, Ziwan Cai, Binggen Wu, Qian Shen, Lijun Chen, Bo Wang, Lixiong Ying, Chenchai Xie, Jing Zheng, Jianya Zhou, Jianying Zhou
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-07-01
coleção:	Journal of Translational Medicine
Assuntos:	SCLC molecular subtypes CD161+CD127+CD8+ T cells Immune profiling Survival outcome CyTOF
Acesso em linha:	https://doi.org/10.1186/s12967-025-06724-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!